CSBR logo

Champions Oncology, Inc. (CSBR)

Profile

Full Name

Champions Oncology, Inc.

Ticker

NASDAQ: CSBR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 2, 2007

Indexes

Not included

Website

http://www.championsoncology.com

Employees

213

Key Details

Price

$6.24(-6.17%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$56.94M(+13.54% YoY)

Annual EPS

$0.33(+161.11% YoY)

PE ratio

19.50

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.24
    CSBR price is $6.24

    30-Day Relative Volume

    1.71
    CSBR 30-day relative volume is 1.71

    Price Performance

    Price Most recent change

    -6.17%
    CSBR price was down -6.17% on Jul 25, 2025

    Price YTD change

    -27.19%
    CSBR price is down -27.19% since January 1st

    Price 1-year change

    +29.73%
    CSBR price is up +29.73% year-on-year

    Price 3-year change

    -26.76%
    CSBR price is down -26.76% over the past 3 years

    Price Range

    Price All-time high

    $25.80
    CSBR price is currently -75.81% below its historical high of $25.80

    Price 3-year low

    $3.60
    CSBR price is currently +73.33% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $86.28M
    CSBR market capitalization is $86.28 million

    Market cap 3-year change

    -25.11%
    CSBR market capitalization is down -25.11% over the past 3 years

    Market cap All-time high

    $195.04M
    CSBR market capitalization is currently -55.76% below its historical high of $195.04 million

    Market cap sector rank

    40.56%
    CSBR market capitalization is higher than 40.56% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.71%
    CSBR shares outstanding is up +1.71% year-on-year

    Shares Outstanding 3-Year Change

    +2.25%
    CSBR shares outstanding is up +2.25% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.71
    CSBR beta is 0.71

    200-day SMA

    $7.46
    CSBR price is currently -16.33% below its 200-day simple moving average

    50-day SMA

    $7.20
    CSBR price is currently -13.31% below its 50-day simple moving average

    RSI

    34.06
    CSBR 14-day relative strength index is 34.06

    Volume

    1.71
    CSBR 30-day relative volume is 1.71

    ATR

    $0.63
    CSBR average true range is $0.63

    10-day Historical Volatility

    85.81%
    CSBR 10-day historical volatility is 85.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $56.94M
    CSBR annual revenue is $56.94 million

    Revenue Analysts estimate

    $61.02M
    CSBR annual revenue is currently -6.68% lower than the consensus analysts' forecast

    Revenue 1-year change

    +13.54%
    CSBR annual revenue is up +13.54% year-on-year

    Revenue Sector rank

    48.57%
    CSBR annual revenue is higher than 48.57% of companies in Healthcare sector

    EPS

    EPS

    $0.33
    CSBR annual earnings per share is $0.33

    EPS Analysts estimate

    $0.22
    CSBR annual earnings per share is currently +50.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +161.11%
    CSBR annual earnings per share is up +161.11% year-on-year

    EPS Sector rank

    85.81%
    CSBR annual earnings per share is higher than 85.81% of companies in Healthcare sector

    Profit

    Gross profit

    $28.55M
    CSBR annual gross profit is $28.55 million

    Gross margin

    50.15%
    CSBR annual gross profit margin is 50.15%

    Operating profit

    $4.85M
    CSBR annual operating income is $4.85 million

    Operating margin

    8.51%
    CSBR annual operating profit margin is 8.51%

    Net income

    $4.70M
    CSBR annual net profit is $4.70 million

    Net margin

    -
    CSBR annual net profit margin value is unknown

    Expenses

    Total expenses

    $52.10M
    CSBR annual total expenses is $52.10 million

    Operating expenses

    $23.71M
    CSBR annual total operating expenses is $23.71 million

    Cost of goods sold

    $28.39M
    CSBR annual cost of goods sold is $28.39 million

    Selling, general & administrative expenses

    $16.88M
    CSBR annual SGA is $16.88 million

    Depreciation and amortization

    $1.64M
    CSBR annual depreciation & amortization is $1.64 million

    Interest expense

    -
    CSBR annual interest expense value is unknown

    Income tax

    -$75.00K
    CSBR annual income tax is -$75.00 thousand

    EBIT & EBITDA

    EBIT

    $4.85M
    CSBR annual earnings before interest & taxes is $4.85 million

    EBITDA

    $6.78M
    CSBR annual EBITDA is $6.78 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $32.34M
    CSBR annual total assets is $32.34 million

    Non current assets

    $9.97M
    CSBR annual long term assets is $9.97 million

    Current assets

    $22.37M
    CSBR annual total current assets is $22.37 million

    Cash and cash equivalents

    $9.79M
    CSBR annual cash & cash equivalents is $9.79 million

    Accounts receivable

    $6.87M
    CSBR annual accounts receivable is $6.87 million

    Inventory

    -
    CSBR annual inventory value is unknown

    Liabilities

    Total liabilities

    $28.57M
    CSBR annual total liabilities is $28.57 million

    Long term liabilities

    $4.72M
    CSBR annual total long term liabilities is $4.72 million

    Current liabilities

    $23.85M
    CSBR annual total current liabilities is $23.85 million

    Accounts payable

    $4.25M
    CSBR annual accounts payable is $4.25 million

    Debt

    Total debt

    $6.11M
    CSBR annual total debt is $6.11 million

    Total debt 1-year change

    -17.83%
    CSBR annual total debt is down -17.83% year-on-year

    Long term debt

    $4.63M
    CSBR annual long term debt is $4.63 million

    Short term debt

    -
    CSBR annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $3.77M
    CSBR annual stockholders equity is $3.77 million

    Book value

    $3.44M
    CSBR annual book value is $3.44 million

    Retained earnings

    -$79.89M
    CSBR annual retained earnings is -$79.89 million

    Working capital

    -$1.48M
    CSBR annual working capital is -$1.48 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $7.39M
    CSBR annual cash flow from operations is $7.39 million

    Cash from operations 1-year change

    +220.35%
    CSBR annual cash flow from operations is up +220.35% year-on-year

    Cash from investing

    -$389.00K
    CSBR annual cash flow from investing activities is -$389.00 thousand

    Cash from investing 1-year change

    +53.47%
    CSBR annual cash flow from investing activities is up +53.47% year-on-year

    Cash from financing

    $170.00K
    CSBR annual cash flow from financing activities is $170.00 thousand

    Cash from financing 1-year change

    +132.26%
    CSBR annual cash flow from financing activities is up +132.26% year-on-year

    CAPEX

    CAPEX

    $389.00K
    CSBR annual capital expenditures is $389.00 thousand

    CAPEX 1-year change

    -53.47%
    CSBR annual capital expenditures is down -53.47% year-on-year

    Free Cash Flow

    Free cash flow

    $7.00M
    CSBR annual free cash flow is $7.00 million

    Free cash flow 1-year change

    +200.34%
    CSBR annual free cash flow is up +200.34% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    50.15%
    CSBR annual gross profit margin is 50.15%

    Operating margin

    8.51%
    CSBR annual operating profit margin is 8.51%

    Net margin

    -
    CSBR annual net profit margin value is unknown

    ROA & ROE

    ROA

    14.53%
    CSBR annual return on assets is 14.53%

    ROE

    124.63%
    CSBR annual return on equity is 124.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    19.50
    CSBR price to earnings ratio is 19.50

    PE ratio Sector rank

    39.15%
    CSBR price to earnings ratio is higher than 39.15% of companies in Healthcare sector

    PB Ratio

    PB ratio

    22.87
    CSBR price to book ratio is 22.87

    PB ratio Sector rank

    95.53%
    CSBR price to book ratio is higher than 95.53% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.52
    CSBR price to sales ratio is 1.52

    PS ratio Sector rank

    32%
    CSBR price to sales ratio is higher than 32% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $82.60M
    CSBR enterprise value is $82.60 million

    Enterprise value Sector rank

    40.87%
    CSBR enterprise value is higher than 40.87% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    12.74
    CSBR EV/EBITDA is 12.74

    EV/EBITDA Sector rank

    86.09%
    CSBR EV/EBITDA is higher than 86.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.94
    CSBR annual current ratio is 0.94

    Quick ratio

    -
    CSBR annual quick ratio value is unknown

    Leverage

    Debt to equity

    1.62
    CSBR annual debt to equity ratio is 1.62

    Interest coverage ratio

    -
    CSBR annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    7
    CSBR piotroski f-score is 7

    Altman Z-Score

    0.55
    CSBR altman z-score is 0.55

    Analyst ratings

    Recent major analysts updates

    Mar 12, 25 Craig-Hallum
    Buy
    Dec 12, 24 Craig-Hallum
    Buy
    Sep 12, 24 Craig-Hallum
    Buy
    Mar 13, 24 Craig-Hallum
    Hold
    Sep 22, 23 Roth MKM
    Buy
    Mar 15, 21 Roth Capital
    Buy
    Nov 18, 19 Benchmark
    Speculative Buy
    Sep 20, 19 Roth Capital
    Buy
    Jul 24, 19 Janney Montgomery Scott
    Neutral
    Jul 24, 19 Janney Capital
    Neutral

    Institutional Ownership

    Screeners with CSBR included

    Growing Shares Outstanding
    US stocks
    High Piotroski score stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Champions Oncology, Inc.?
    • Does Champions Oncology, Inc. pay dividends?
    • What sector is Champions Oncology, Inc. in?
    • What industry is Champions Oncology, Inc. in?
    • What country is Champions Oncology, Inc. based in?
    • When did Champions Oncology, Inc. go public?
    • Is Champions Oncology, Inc. in the S&P 500?
    • Is Champions Oncology, Inc. in the NASDAQ 100?
    • Is Champions Oncology, Inc. in the Dow Jones?
    • When was Champions Oncology, Inc.'s last earnings report?
    • When does Champions Oncology, Inc. report earnings?

    What is the ticker symbol for Champions Oncology, Inc.?

    The ticker symbol for Champions Oncology, Inc. is NASDAQ:CSBR

    Does Champions Oncology, Inc. pay dividends?

    No, Champions Oncology, Inc. does not pay dividends

    What sector is Champions Oncology, Inc. in?

    Champions Oncology, Inc. is in the Healthcare sector

    What industry is Champions Oncology, Inc. in?

    Champions Oncology, Inc. is in the Biotechnology industry

    What country is Champions Oncology, Inc. based in?

    Champions Oncology, Inc. is headquartered in United States

    When did Champions Oncology, Inc. go public?

    Champions Oncology, Inc.'s initial public offering (IPO) was on February 2, 2007

    Is Champions Oncology, Inc. in the S&P 500?

    No, Champions Oncology, Inc. is not included in the S&P 500 index

    Is Champions Oncology, Inc. in the NASDAQ 100?

    No, Champions Oncology, Inc. is not included in the NASDAQ 100 index

    Is Champions Oncology, Inc. in the Dow Jones?

    No, Champions Oncology, Inc. is not included in the Dow Jones index

    When was Champions Oncology, Inc.'s last earnings report?

    Champions Oncology, Inc.'s most recent earnings report was on July 24, 2025

    When does Champions Oncology, Inc. report earnings?

    The date for Champions Oncology, Inc.'s next earnings report has not been announced yet
    On this page